Oliver Vandrey
Erlangen, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Interferon-β and FTY720 ameliorate progressive CNS inflammation via SOCS1-associated astrocyte signaling.
Journal: Scientific reports
Published: November 27, 2025
Serum Levels of Aryl Hydrocarbon Receptor Plasma Agonist Activity Are Reduced in Patients With NMOSD and Correlate With Disease Activity.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: August 05, 2025
TGFα controls checkpoints in CNS resident and infiltrating immune cells to promote resolution of inflammation.
Journal: Nature communications
Published: January 03, 2024
The astrocyte-produced growth factor HB-EGF limits autoimmune CNS pathology.
Journal: Nature immunology
Published: March 09, 2023
Regulation of the programmed cell death protein 1/programmed cell death ligand 1 axis in relapsing-remitting multiple sclerosis.
Journal: Brain communications
Published: January 13, 2023
PD-L1 positive astrocytes attenuate inflammatory functions of PD-1 positive microglia in models of autoimmune neuroinflammation.
Journal: Nature communications
Published: December 09, 2022
Astrocyte-Derived Pleiotrophin Mitigates Late-Stage Autoimmune CNS Inflammation.
Journal: Frontiers in immunology
Published: October 22, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026